Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Impax Laboratories Inc

+ Add to Watchlist

IPXL:US

36.6700 USD 1.0200 2.71%

As of 20:10:00 ET on 01/30/2015.

Company Profile for Impax Laboratories Inc (IPXL)

Impax Laboratories, Inc. develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. The Company specializes in the development of niche and controlled release generics, as well as the development of branded products.

Contact Information

Impax Laboratories Inc

30831 Huntwood Avenue
Hayward, CA 94544
United States
Phone: 1-510-476-2000
Fax: 1-510-471-3200

Key Executives for Impax Laboratories Inc (IPXL)

George Frederick Wilkinson "Fred"President/CEOMichael J NestorPres:Impax Pharmaceuticals
Bryan M ReasonsSenior VP:Finance/CFOMark A SchlossbergSenior VP/Secy/General Counsel
Mark DonohueVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil